Pharmaceuticals - Community Register

  

Community list of not active medicinal products for human use


WITHDRAWN  

Product information

Invented name: Vitrasert implant
Auth. number : EU/1/97/034
INN : ganciclovir
ATC: Anatomical main group: J - General antiinfectives for systemic use
Therapeutic subgroup: J05 - Antivirals for systemic use
Pharmacological subgroup: J05A - Agents affecting the virus directly
Chemical subgroup: J05AB - Nucleosides
Chemical substance: J05AB06 - Ganciclovir
(See WHO ATC Index)
Indication: Treatment of CMV renititis in patient with AIDS
Marketing Authorisation Holder: Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH
Brunsbuetteler Damm 165-173, D-13581Berlin (Spandau), Deutschland

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/03/1997 Centralised - Authorisation EMEA/H/C/120 (97)784 of 18/03/1997
27/07/2000 Centralised - Variation EMEA/H/C/120/I/2
29/12/2000 Centralised - Variation EMEA/H/C/120/I/3 (2000)3987 of 27/12/2000
04/04/2002 Centralised - Withdrawal (2002)1371 of 02/04/2002